755.65

INR
-4.30(-0.57%)
As of November 14, 2024 10:00:00 AM

Vimta Labs Limited Share Price Information

24 hour Low and High

Low: 755.65002441
High: 755.65002441

All time High

759.95

Price Change 1h

+₹0.00 +0.00%

Price Change 1d

+₹0.00 +0.00%

Price Change 1w

+₹61.60 +8.88%

Vimta Labs Limited Market Information

Exchange

NSE

Market Cap

1232.37 Cr

About Vimta Labs Limited Share

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, clinical diagnostics, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Sector

Healthcare

Diagnostics & Research

Employees

about

1428

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%
  • Vimta Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Insider Sales At Vimta Labs Landed A Good Price
  • Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore
  • 44 stocks scale to 52-week highs including KIMS and Vimta Labs as JSW Holdings leads the gains

FAQs

755.65

INR
-4.30(-0.57%)
As of November 14, 2024 10:00:00 AM

Vimta Labs Limited Share Price Information

24 hour Low and High

Low: 755.65002441
High: 755.65002441

All time High

759.95

Price Change 1h

+₹0.00 +0.00%

Price Change 1d

+₹0.00 +0.00%

Price Change 1w

+₹61.60 +8.88%

Vimta Labs Limited Market Information

Exchange

NSE

Market Cap

1232.37 Cr

About Vimta Labs Limited Share

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, clinical diagnostics, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Sector

Healthcare

Diagnostics & Research

Employees

about

1428

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%
  • Vimta Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Insider Sales At Vimta Labs Landed A Good Price
  • Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore
  • 44 stocks scale to 52-week highs including KIMS and Vimta Labs as JSW Holdings leads the gains

FAQs